RetractedReviewBioMed research international2022

Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.

Yingkun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.